Understanding TERT Promoter Mutations: A Common Path to Immortality

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Telomerase activation is crucial for cancer development, enabling unlimited cell division by maintaining telomere length.
• TERT promoter mutations are highly prevalent across numerous cancer types, representing a key driver of tumorigenesis.
• TERT is normally silenced in differentiated cells but active in stem cells, suggesting mutation presence may indicate tumor origin.

Purpose of the Study:

• To review the widespread role of TERT promoter mutations in cancer.
• To discuss recent advances in understanding the mechanism of TERT transcriptional activation by these mutations.
• To highlight the potential of TERT mutations as biomarkers and therapeutic targets.

Main Methods:

• Literature review focusing on TERT promoter mutations in tumorigenesis.
• Analysis of mechanisms underlying TERT transcriptional activation.
• Evaluation of TERT mutations as biomarkers for patient outcome.

Main Results:

• TERT promoter mutations are a fundamental and widespread mechanism in tumorigenesis, found in over 50 cancer types.
• These mutations activate TERT transcription early in cellular transformation by recruiting aberrant transcription factors.
• Both somatic TERT promoter mutations and germline variations in the TERT locus show promise as biomarkers.

Conclusions:

• TERT promoter mutations play a critical role in initiating and sustaining cancer by enabling cellular immortality.
• Understanding the molecular mechanisms of TERT activation by mutations can lead to new cancer-specific therapies.
• TERT mutations and variations are valuable biomarkers for predicting patient outcomes.